Congruent with these data, unselected SCLC patients with NOTCH1-positive tumors by IHC were previously shown to have shorter survival with chemotherapy than unselected SCLC patients with NOTCH1-negative tumors (55). The gene discussed is NOTCH1; the disease is small cell lung carcinoma.